Li-yu Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Journal: Science advances

Published: November 29, 2023

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.

Journal: Clinical epigenetics

Published: June 07, 2021

Inhibition of PTEN activity promotes IB4-positive sensory neuronal axon growth.

Inhibition of PTEN activity promotes IB4-positive sensory neuronal axon growth.

Journal: Journal of cellular and molecular medicine

Published: November 10, 2019

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome.

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome.

Journal: Leukemia & lymphoma

Published: October 01, 2016

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.

Journal: Scientific reports

Published: September 05, 2016

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Journal: American journal of translational research

Published: May 28, 2016

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Journal: Nature communications

Published: May 28, 2015

Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.

Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.

Journal: PloS one

Published: November 30, 2013

Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma

Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 22, 2012

Cytogenetic study of autosomal monosomies among myelodysplastic syndrome patients

Cytogenetic study of autosomal monosomies among myelodysplastic syndrome patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 22, 2012

Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.

Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.

Journal: PloS one

Published: October 30, 2012

Clinical therapeutic efficacy of rituximab for relapsed and refractory idiopathic thrombocytopenic purpura

Clinical therapeutic efficacy of rituximab for relapsed and refractory idiopathic thrombocytopenic purpura

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 31, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026